1-deoxynojirimycin has been researched along with moxalactam in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XK; Dong, Q; Guo, YJ; Jin, F; Kou, C; Luo, XJ; Qi, H; Qi, X; Qi, YJ; Shen, AD; Shen, YH; Shi, HY; Tang, BH; Wang, YC; Wu, YE; Zhao, W; Zheng, Y | 1 |
1 other study(ies) available for 1-deoxynojirimycin and moxalactam
| Article | Year |
|---|---|
Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants.
Topics: 1-Deoxynojirimycin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Moxalactam; Plasma; Prospective Studies | 2019 |